Biotechnology Oversight Coordination Act of 2024
Latest Action
Referred to the Subcommittee on Conservation, Research, and Biotechnology.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Biotechnology Oversight Coordination Act of 2024 is a House bill introduced in the 118th Congress aimed at improving coordination of biotechnology oversight. The bill was referred to the Subcommittee on Conservation, Research, and Biotechnology but did not advance further and is currently classified as failed or expired. No official summary or full text is available, limiting detailed analysis. The bill falls under the policy area of Science, Technology, and Communications and appears intended to address regulatory or oversight mechanisms related to biotechnology.
This bill sought to enhance coordination in biotechnology oversight but did not progress beyond subcommittee referral and is now expired.
- Introduced in the House during the 118th Congress as H.R. 8538.
- Referred to the Subcommittee on Conservation, Research, and Biotechnology on September 3, 2024.
- No official summary or full text is publicly available, limiting detailed content analysis.
- Classified as failed or expired, indicating it did not pass into law.
- Falls within the Science, Technology, and Communications policy area.
['Federal agencies involved in biotechnology regulation and oversight', 'Biotechnology research organizations and industry stakeholders', 'Subcommittee on Conservation, Research, and Biotechnology']
['Lack of publicly available full text and summary limits transparency and understanding of specific provisions.', 'Unclear funding mechanisms or enforcement authorities due to missing text.', 'Potential challenges in implementation and interagency coordination not detailed.', 'No information on oversight or accountability measures.']
The bill was introduced during the 118th Congress and referred to a relevant subcommittee but did not advance further, resulting in its failure or expiration. This suggests limited legislative momentum or prioritization within the current congressional session. The focus on biotechnology oversight aligns with ongoing federal interests in regulating emerging technologies within science and technology policy domains.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential for improved interagency coordination in biotechnology oversight if enacted.', 'Possible influence on future legislative efforts to regulate biotechnology.', 'Could affect research and development practices in biotechnology through enhanced oversight frameworks.']
The absence of an official summary and full bill text significantly limits transparency and public understanding of the bill's provisions and potential impacts. This lack of information poses challenges for effective oversight and informed public discourse. Monitoring future related legislation for improved disclosure and clarity is advisable.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.